Bionano Genomics prices offering of 29 million shares at discount of $3.05 a share

/ / News

Bionano Genomics Inc. said Friday it has priced an underwritten public offering of 29 million shares at $3.05 a share. The stock closed Thursday at $5.00. The genome analysis company has granted the underwriters — Oppenheimer & Co., which is sole bookrunner, while BTIG acted as lead manager and Ladenburg Thalman and Maxim Group acting as co-managers — a 30-day option to acquire an additional 4.3 million shares at the offering price. The stock, which has been volatile in recent sessions, slid 18% premarket, but is up more than 300% in the last 12 months, while the SPDR S&P Biotech ETF has gained 58% and the S&P 500 has gained 17.5%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.